No insider purchase over the last 90 days. The latest, by 임호용, was filed 27 Jul 2026.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 1,100 sharesShareKRXDART:20260727000241Canonical exit: 25 Oct 2026 (T+90)
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- ●Executives0DART
- ●Executives0DART
- 1,000 sharesShareKRXDART:20241120000062Canonical exit: 18 Feb 2025 (T+90)
- ShareKRXDART:20230627000087Canonical exit: 21 Sept 2023 (T+90)
- 43,573 sharesKRXDART:20230407003025Canonical exit: 6 Jul 2023 (T+90)
- 26,427 sharesKRXDART:20230404002560
- ShareKRXDART:20230404001825Canonical exit: 3 Jul 2023 (T+90)
- ●Executives0DART
- ShareKRXDART:20230310000999Canonical exit: 8 Jun 2023 (T+90)
- 44,734 sharesKRXDART:20220609000179
- ShareKRXDART:20220415000240Canonical exit: 14 Jul 2022 (T+90)
- 1,553 sharesKRXDART:20220404002767Canonical exit: 3 Jul 2022 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
25 of 37 declarations
About GC Cell Corporation
Three people drive the filings at 지씨셀 (GC Cell Corporation): 전지원 (본부장) files 11, all purchases, 임호용 (본부장) adds one, and 녹십자 signs 6, including 2 purchases and one sale. The company itself has 8 filings with no trade, and 국민연금공단 has 3, with one sale. No amount is stated.
In all, 14 purchases against 2 sales: 88% purchases among open-market trades. Between March 10 and April 7, 2023, 2 distinct filers bought. Dated trades gather on a single day, June 23, 2023, whereas the 29 filings were published from March 9, 2021 to July 27, 2026: 14 in 2021, 5 in 2022, 6 in 2023, then 1, 1 and 2.
Read moreShow less
A South Korean health care company, KRW 205.3 billion of capitalisation, 42.7% of the capital with insiders, 5 filers. The two filings of the latest year include one purchase. In all, 13 filings are neither purchases nor sales. Seen over five years, the pace slows: 14 filings in 2021 against 2 in the last twelve months.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
